Pregabalin Capsule
Product Images NDC 82968-009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82968-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fourrts (india) Laboratories Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Pregabalin 100mg 100s Carton)

FDA Label Image

Image (Pregabalin 100mg 10s Blis)

Image (Pregabalin 100mg 10s Blis)
This text seems to be detailing information about Pregabalin capsules in 100mg strength manufactured by Fourrts LLC, a pharmaceutical company based in Park Ridge, NJ. The capsules are prescribed for specific medical conditions and are marked with a barcode for tracking purposes. Please note that detailed dosage instructions and usage information are likely available on the packaging or within the accompanying documentation.*
FDA Label Image

Image (Pregabalin 100mg 90s Bot)

FDA Label Image

Image (Pregabalin 150mg 100s Carton)

FDA Label Image

Image (Pregabalin 150mg 10s Blis)

Image (Pregabalin 150mg 10s Blis)
This text appears to be a list of details related to Pregabalin capsules of 150 mg strength manufactured by Fourrts LLC. The information includes barcode details, company address, and indications for use. It mentions that the product is to be used under prescription (Rx Only).*
FDA Label Image

Image (Pregabalin 150mg 90s Bot)

FDA Label Image

Image (Pregabalin 200mg 90s Bot)

Image (Pregabalin 200mg 90s Bot)
This is a description not-available.*
FDA Label Image

Image (Pregabalin 225mg 90s Bot)

Image (Pregabalin 225mg 90s Bot)
This text is related to medication information for Pregabalin capsules. It mentions the dosage of 225 mg and advises dispensing the accompanying Medication Guide to each patient. The product is manufactured by Fours Pharmacists USALLC in India. It provides the NDC code, storage instructions, and manufacturer details. Additional details may be available in the missing parts of the text.*
FDA Label Image

Image Description (Pregabalin 25mg 90s Bot)

FDA Label Image

Image (Pregabalin 300mg 90s Bot)

Image (Pregabalin 300mg 90s Bot)
This text provides information about Pregabalin capsules, each containing 300 mg of Pregabalin. It includes details on dosage, storage conditions, and manufacturer information. The text instructs to dispense in light-resistant (USP), child-resistant containers and to store at temperatures between 15°C to 30°C (59°F to 86°F). It also mentions the need to refer to accompanying prescribing information and dispense the Medication Guide to each patient. The product is distributed in the USA by Fourts Pharmaceuticals USA LLC.*
FDA Label Image

Image (Pregabalin 50mg 100s Carton)

FDA Label Image

Image (Pregabalin 50mg 10s Blis)

FDA Label Image

Image (Pregabalin 50mg 90s Bot)

FDA Label Image

Image (Pregabalin 75mg 100s Carton)

FDA Label Image

Image (Pregabalin 75mg 10s Blis)

FDA Label Image

Image (Pregabalin 75mg 90s Bot)

FDA Label Image

Figure 6 (Pregabalin Bar 1)

FDA Label Image

Figure 8 (Pregabalin Bar 2)

FDA Label Image

Figure 1 (Pregabalin Fig 1)

FDA Label Image

Figure 12 (Pregabalin Fig 10)

Figure 12 (Pregabalin Fig 10)
Percent of Subjects improved is 50% at Week 16 based on the Baseline to Week 16 BOCF analysis.*
FDA Label Image

Figure 2 (Pregabalin Fig 2)

FDA Label Image

Figure 3 (Pregabalin Fig 3)

FDA Label Image

Figure 4 (Pregabalin Fig 4)

FDA Label Image

Figure 5 (Pregabalin Fig 5)

Figure 5 (Pregabalin Fig 5)
This text provides information on the percentage of patients who improved with two medications - Pregabalin and Progabalin. Pregabalin was taken 100 milligrams three times a day, while Progabalin was taken 80 milligrams four times a day. The percentage of improvement in pain from the baseline is also mentioned.*
FDA Label Image

Figure 7 (Pregabalin Fig 6)

FDA Label Image

Figure 9 (Pregabalin Fig 7)

FDA Label Image

Figure 10 (Pregabalin Fig 8)

Figure 10 (Pregabalin Fig 8)
Not available.*
FDA Label Image

Figure 11 (Pregabalin Fig 9)

Figure 11 (Pregabalin Fig 9)
This text provides information on the percentage of subjects who improved after taking Pregabalin from baseline to week 12 using BOCF (Baseline Observation Carried Forward) analysis. The data shows 90% to 100% improvement.*
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

Cockcroft And Gault Equation (Pregabalin Formula)
This text provides a formula for calculating estimated glomerular filtration rate (eGFR) based on serum creatinine levels and weight. The formula involves multiplying the weight (in kg) by the serum creatinine level (in mg/dl), and then adjusting for gender by multiplying the result by 0.85 for female patients. This calculation can help estimate kidney function, particularly in the context of assessing renal health.*
FDA Label Image

Chemical Structure (Pregabalin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.